Table 3.
Total (n = 110) | Cirrhosis (n = 55) | Non-cirrhosis (n = 55) | p-value | |
---|---|---|---|---|
Age (years) | 65.0 ± 1.4 | 61.1 ± 2.0 | 68.9 ± 2.0 | 0.006 |
Male/Female | 79/31 | 40/15 | 39/16 | NS(0.832) |
Length of ICU stay (days) | 14 ± 1 | 11 ± 1 | 18 ± 2 | 0.007 |
Length of Hospital stay (days) | 31 ± 2 | 32 ± 4 | 31 ± 3 | NS(0.843) |
Body weight on ICU admission (kg) | 60 ± 1 | 64 ± 2 | 56 ± 2 | 0.001 |
GCS, ICU first day (points) | 10 ± 0 | 11 ± 1 | 8 ± 1 | 0.005 |
MAP, ICU admission (mmHg) | 78 ± 2 | 83 ± 2 | 73 ± 2 | 0.002 |
Serum Creatinine, ICU first day (mg/dl) | 2.4 ± 0.2 | 1.8 ± 0.2 | 3.0 ± 0.3 | 0.004 |
Arterial HCO3 −, ICU first day | 21 ± 1 | 20 ± 1 | 21 ± 1 | NS(0.458) |
Serum Sodium, ICU first day (mg/dl) | 137 ± 1 | 138 ± 1 | 137 ± 1 | NS(0.282) |
Bilirubin, ICU first day (mg/dl) | 5.8 ± 0.8 | 9.6 ± 1.5 | 1.9 ± 0.4 | <0.001 |
Albumin, ICU first day (g/l) | 2.4 ± 0.1 | 2.5 ± 0.1 | 2.3 ± 0.1 | 0.016 |
Blood Sugar, ICU first day (mg/dl) | 160 ± 8 | 159 ± 12 | 161 ± 11 | NS(0.899) |
Hemoglobin, ICU first day (g/dl) | 9.7 ± 0.2 | 9.3 ± 0.3 | 10.0 ± 0.3 | NS(0.134) |
Platelets, ICU first day (×103/μL) | 127.3 ± 10.1 | 85.8 ± 8.1 | 168.8 ± 16.9 | <0.001 |
Leukocytes, ICU first day (×103/μL) | 13.9 ± 0.8 | 12.9 ± 1.3 | 14.9 ± 1.0 | NS(0.224) |
PaO2/FiO2, ICU first day(mmHg) | 256 ± 13 | 270 ± 16 | 243 ± 19 | NS(0.299) |
Shock(%) | 39 (35.5) | 9 (16.3) | 30 (54.5) | <0.001 |
Hospital mortality (%) | 71(64.5) | 34 (61.8) | 37 (67.3) | NS(0.550) |
Score systems | ||||
APACHE III, ICU first day(mean ± SE) | 86.5 ± 2.8 | 81.1 ± 4.2 | 91.9 ± 3.7 | NS(0.058) |
SOFA, ICU first day(mean ± SE) | 10.0 ± 0.3 | 10.0 ± 0.5 | 10.0 ± 0.3 | NS(0.927) |
RIFLE, ICU first day(mean ± SE) | 1.6 ± 0.1 | 1.4 ± 0.2 | 1.9 ± 0.2 | 0.041 |
Abbreviation: NS, not significant; ICU, intensive care unit; SE, standard error; GCS, Glasgow coma scale; MAP, mean arterial pressure; PaO2, arterial partial pressure of oxygen; FiO2, fraction of inspired oxygen; APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, sequential organ failure assessment; RIFLE, risk of renal failure, injury to the kidney, failure of kidney function, loss of kidney function, and end-stage renal failure.